1 story in the last 7 days
The latest insider buying news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks insider buying across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
A veteran pharma venture capital insider purchased 25,000 shares of Nuvation Bio as its new drug gains momentum. The insider's buy signals confidence in the company's pipeline. Nuvation Bio is developing therapies for oncology.
Summaries by ByteBrief